Request more information
The TrueMark Respiratory Panel 2.0 has been updated with targets for today’s critical pathogens, so you get even more answers the first time. With extended coverage that includes SARS-CoV-2 targets, this panel features the most respiratory pathogen targets of any test on the market, at the lowest cost per sample, to help you identify key respiratory infections and study SARS-CoV-2 co-infections quickly and cost-effectively.
- Extensive coverage including SARS-CoV-2 targets— our solution features the largest number of respiratory pathogen targets of any test on the market
- Cost-effective—lowest cost per sample when compared to other commercially available molecular solutions
- Multiple sample input types—including nasopharyngeal (NP) swabs, bronchoalveolar lavage (BAL), and nasal aspirate